bufalin has been researched along with methotrexate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, QC; Huang, G; Jin, S; Li, FB; Li, HM; Shen, JN; Su, WW; Wang, J; Yin, JQ; Zou, CY | 1 |
Huang, G; Jia, Q; Shen, JN; Wang, J; Xie, XB; Yin, JQ; Zou, CY | 1 |
2 other study(ies) available for bufalin and methotrexate
Article | Year |
---|---|
Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Bufanolides; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Drug Resistance, Neoplasm; Humans; Methotrexate; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; Tetrahydrofolate Dehydrogenase | 2007 |
[Bufalin induces apoptosis in osteosarcoma U-2OS and U-2OS methotrexate 300-resistant cell lines in vitro].
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Bone Neoplasms; Bufanolides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Methotrexate; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; Tetrahydrofolate Dehydrogenase; Tumor Suppressor Protein p53 | 2010 |